IMU Biosciences partners with Waters to advance IMU’s AI-driven immunology platform to transform diagnosis and monitoring: London, UK Friday, June 26, 2026, 12:00 Hrs [IST] IMU ...
Waters Corporation (NYSE: WAT) and IMU Biosciences have formed a strategic partnership to advance an AI-powered immune ...
IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a ...
A large body of research publications covering hematological disorders, such as acute myeloid leukemia (AML) and multiple myeloma (MM), demonstrates that measurable minimal disease (MRD) neg ...
This guide examines the core principles that underpin robust flow cytometry workflows, connecting established best practices with modern spectral capabilities to help laboratories generate more ...
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue was ...
New 7-Laser Cytek Borealisâ„¢ System With Deep Ultraviolet and Infrared cFluor® Reagents; Cytek Auroraâ„¢ Evo System Enhancements for Automation and Workflow Efficiency Cytek Borealisâ„¢ Full Spectrum Flow ...
Flow cytometry is a high-throughput, laser-based analytical method used to quantify physical and biochemical characteristics of individual cells or particles suspended in fluid as they pass ...
Impedance flow cytometry measurements are adversely affected by the distance between the analyte and the sensing electrodes. By slightly squeezing the microfluidic channel, adapts the channel’s height ...
Figure 11: U.K. Flow Cytometry Market, $Million, 2024-2035 Figure 12: Germany Flow Cytometry Market, $Million, 2024-2035 Figure 13: France Flow Cytometry Market ...
Abstract: This paper presented a high-quality imaging flow cytometry based on acoustic focusing with demonstrative applications in label-free leukocyte differential coupled with deep neural network.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results